We are live on ! Find out more
OC

Oppenheimer & Co Portfolio holdings

AUM $8.21B
1-Year Est. Return 28.81%
This Fund
S&P 500
This Quarter Est. Return
+3.78%
1 Year Est. Return
+28.81%
3 Year Est. Return
+92.54%
5 Year Est. Return
+114.67%
10 Year Est. Return
+429.8%
AUM
$3.48B
AUM Growth
+$121M
Cap. Flow
+$68.3M
Cap. Flow %
1.96%
Top 10 Hldgs %
12.54%
Holding
1,594
New
179
Increased
532
Reduced
584
Closed
199

Top Buys

Rank Stock Value
1
BABA icon
Alibaba
BABA
+$8.12M
2
KMI icon
Kinder Morgan
KMI
+$7.34M
3
ILMN icon
Illumina
ILMN
+$6.91M
4
DD icon
DuPont de Nemours
DD
+$6.77M
5
NVGS icon
Navigator Holdings
NVGS
+$6.1M

Sector Composition

Rank Sector Weight
1 Healthcare 12.04%
2 Industrials 10.15%
3 Energy 9.83%
4 Financials 9.31%
5 Technology 9.29%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
OMCL icon
826
Omnicell
OMCL
$1.61B
$493K 0.01%
+14,900
New +$460K
MUE
827
DELISTED
BlackRock MuniHoldings Quality Fund II
MUE
$491K 0.01%
36,389
+22,846
+169% +$304K
JAH
828
DELISTED
JARDEN CORPORATION
JAH
$491K 0.01%
10,249
+808
+9% +$35.1K
BSET icon
829
Bassett Furniture
BSET
$164M
$488K 0.01%
25,009
LEA icon
830
Lear
LEA
$6.54B
$487K 0.01%
4,963
+2,241
+82% +$206K
SRPT icon
831
Sarepta Therapeutics
SRPT
$1.57B
$487K 0.01%
33,700
+22,425
+199% +$380K
GMCR
832
DELISTED
KEURIG GREEN MTN INC
GMCR
$487K 0.01%
3,675
-320
-8% -$45.4K
SNCR
833
DELISTED
Synchronoss Technologies
SNCR
$486K 0.01%
1,289
-611
-32% -$247K
RDIV icon
834
Invesco S&P Ultra Dividend Revenue ETF
RDIV
$1.38B
$484K 0.01%
15,945
+2,830
+22% +$83.3K
BHC icon
835
Bausch Health
BHC
$2.57B
$481K 0.01%
3,360
-50
-1% -$6.72K
FFC
836
Flaherty & Crumrine Preferred and Income Securities Fund
FFC
$777M
$481K 0.01%
25,233
-1,687
-6% -$33.9K
SLCA
837
DELISTED
U.S. SILICA HOLDINGS, INC.
SLCA
$481K 0.01%
18,700
-458
-2% -$18.1K
CLH icon
838
Clean Harbors
CLH
$16.5B
$479K 0.01%
+9,950
New +$485K
BIV icon
839
Vanguard Intermediate-Term Bond ETF
BIV
$28.8B
$478K 0.01%
5,645
-703
-11% -$59.8K
JEF icon
840
Jefferies Financial Group
JEF
$12.6B
$478K 0.01%
23,821
+3,459
+17% +$71.4K
AVP
841
DELISTED
Avon Products, Inc.
AVP
$477K 0.01%
50,765
-4,902
-9% -$50.7K
NFJ
842
Virtus Dividend, Interest & Premium Strategy Fund
NFJ
$1.41B
$476K 0.01%
29,775
CEQP
843
DELISTED
Crestwood Equity Partners LP
CEQP
$476K 0.01%
5,873
-8,338
-59% -$708K
NUVA
844
DELISTED
NuVasive, Inc.
NUVA
$476K 0.01%
10,096
+600
+6% +$25K
ALK icon
845
Alaska Air
ALK
$5.29B
$475K 0.01%
7,944
-4,875
-38% -$257K
WHR icon
846
Whirlpool
WHR
$2.43B
$475K 0.01%
2,455
-240
-9% -$41.2K
CMCM
847
Cheetah Mobile
CMCM
$86.6M
$473K 0.01%
6,261
+1,153
+23% +$100K
MSI icon
848
Motorola Solutions
MSI
$72.3B
$471K 0.01%
7,028
-42
-0.6% -$2.68K
FIS icon
849
Fidelity National Information Services
FIS
$23.1B
$470K 0.01%
7,550
-2,692
-26% -$158K
AFT
850
DELISTED
Apollo Senior Floating Rate Fund Inc.
AFT
$468K 0.01%
28,135
-2,100
-7% -$35.6K

Similar funds

Oppenheimer & Co's Q4 2014 Portfolio in Review

As of Q4 2014, Oppenheimer & Co held 1,594 positions worth $3.48B, up 3.6% from $3.36B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

Oppenheimer & Co's Q4 2014 filing shows 179 new, 532 increased, 584 reduced and 199 closed positions. Its largest new stake was First American: 99,605 shares worth $3.38M. The largest sale was IBM, an estimated $5.56M.

By sector, the portfolio is most concentrated in Healthcare at 12% of assets, up from 11% a quarter earlier, followed by Industrials and Energy.

  • Oppenheimer & Co's largest Q4 2014 buy was First American: 99,605 shares worth $3.38M.
  • Oppenheimer & Co added most to Alibaba in Q4 2014, an estimated $8.12M increase.
  • Oppenheimer & Co's biggest Q4 2014 reduction was IBM, cutting an estimated $5.56M.
  • Oppenheimer & Co fully exited Tesla in Q4 2014, selling an estimated $4.59M.
  • Oppenheimer & Co's ten largest holdings make up 13% of its $3.48B portfolio in Q4 2014.
  • Oppenheimer & Co opened 179 new positions and closed 199 in Q4 2014.
  • Oppenheimer & Co's portfolio value rose 3.6% quarter-over-quarter to $3.48B.

Based on Oppenheimer & Co's 13F filing for Q4 2014, filed 10 Feb 2015.